DK2389923T3 - Stabil klar til brug injicerbar paracetamol-formulering - Google Patents

Stabil klar til brug injicerbar paracetamol-formulering

Info

Publication number: DK2389923T3
Authority: DK; Denmark
Prior art keywords: use injectable; stable ready; acetaminophen formulation; acetaminophen; formulation
Prior art date: 2010-05-19

Application number

DK10005258.8T

Other languages

English (en)

Inventor

Ioulia Tseti

Original Assignee

Uni Pharma Kleon Tsetis Pharmaceutical Lab S A

Ioulia Tseti

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-05-19

Filing date

2010-05-19

Publication date

2013-03-18

2010-05-19 Application filed by Uni Pharma Kleon Tsetis Pharmaceutical Lab S A, Ioulia Tseti filed Critical Uni Pharma Kleon Tsetis Pharmaceutical Lab S A

2013-03-18 Application granted granted Critical

2013-03-18 Publication of DK2389923T3 publication Critical patent/DK2389923T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Inorganic Chemistry (AREA)
Pain & Pain Management (AREA)
Dermatology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK10005258.8T 2010-05-19 2010-05-19 Stabil klar til brug injicerbar paracetamol-formulering DK2389923T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP10005258A EP2389923B1 (en)	2010-05-19	2010-05-19	Stable ready to use injectable paracetamol formulation

Publications (1)

Publication Number	Publication Date
DK2389923T3 true DK2389923T3 (da)	2013-03-18

Family

ID=42338244

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK10005258.8T DK2389923T3 (da)	2010-05-19	2010-05-19	Stabil klar til brug injicerbar paracetamol-formulering

Country Status (21)

Country	Link
US (1)	US8877817B2 (da)
EP (1)	EP2389923B1 (da)
CN (1)	CN102985069B (da)
AP (1)	AP3151A (da)
BR (1)	BR112012029212A2 (da)
CA (1)	CA2799666C (da)
CY (1)	CY1113999T1 (da)
DK (1)	DK2389923T3 (da)
ES (1)	ES2403121T3 (da)
HR (1)	HRP20130184T1 (da)
MA (1)	MA34314B1 (da)
MY (1)	MY160458A (da)
PL (1)	PL2389923T3 (da)
PT (1)	PT2389923E (da)
RU (1)	RU2519764C1 (da)
SI (1)	SI2389923T1 (da)
SM (1)	SMT201300038B (da)
TN (1)	TN2012000516A1 (da)
UA (1)	UA104381C2 (da)
WO (1)	WO2011144335A1 (da)
ZA (1)	ZA201208605B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA201300398B (en) *	2012-11-27	2013-09-25	Genfarma Laboratories S L	Injectable liquid formulation of the combination of tramadol and paracetamol
WO2016008546A1 (en) *	2014-07-18	2016-01-21	Everbright Pharmaceuticals S.A.R.L.	Aqueous formulation comprising paracetamol and ibuprofen
CN105797166A (zh) *	2016-03-30	2016-07-27	吉林长白山药业集团股份有限公司	用羟丙基环糊精包合对乙酰氨基酚制成液体制剂的方法
WO2018192664A1 (en)	2017-04-20	2018-10-25	Hyloris Developments Sa	METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
WO2019180072A1 (en)	2018-03-22	2019-09-26	Bayer Pharma Aktiengesellschaft	Parenteral pharmaceutical composition comprising neladenoson bialanate
WO2021222835A1 (en) *	2020-04-30	2021-11-04	Purser Danny C	Compositions and methods comprising stable reduced glutathione
GR1010637B (el) *	2023-01-13	2024-02-15	Ιουλια Κλεωνος Τσετη	Σταθερο υδατικο διαλυμα παρακεταμολης για χρηση σε ενδοφλεβια εγχυση
GR1010809B (el) *	2023-09-13	2024-10-25	Ιουλια Τσετη	Υδατικο διαλυμα ιβουπροφαινης παρακεταμολης για χρηση σε ενδοφλεβια χορηγηση
AU2024281739A1 (en)	2023-06-02	2025-11-27	Ioulia Tseti	Pharmaceutical composition comprising ibuprofen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH648371A5 (de)	1982-01-29	1985-03-15	Fischer Ag Georg	Anschlusseinrichtung fuer armaturen.
US4727064A (en)	1984-04-25	1988-02-23	The United States Of America As Represented By The Department Of Health And Human Services	Pharmaceutical preparations containing cyclodextrin derivatives
FR2751875B1 (fr)	1996-08-05	1998-12-24	Scr Newpharm	Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
JP2001233787A (ja) *	2000-02-04	2001-08-28	Patents Exploitation Co Bv	小・中サイズのペプチド含有薬学的組成物
US20040045546A1 (en) *	2002-09-05	2004-03-11	Peirce Management, Llc	Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use
FR2851164B1 (fr) *	2003-02-14	2005-04-22	Xuan Tho Nguyen	Formulation liquide injectable de paracetamol
JP5909750B2 (ja) *	2007-11-13	2016-04-27	マリンクロットアイピー	低用量静脈内アセトアミノフェン
US20110015273A1 (en) *	2008-01-17	2011-01-20	Rajnarayana Kandhagatla	Stable pharmaceutical aqueous compositions
US20090246276A1 (en) *	2008-01-28	2009-10-01	Graham Jackson	Pharmaceutical Compositions
WO2009107380A1 (ja) *	2008-02-29	2009-09-03	明治乳業株式会社	抗アレルギー剤

2010
- 2010-05-19 EP EP10005258A patent/EP2389923B1/en active Active
- 2010-05-19 PL PL10005258T patent/PL2389923T3/pl unknown
- 2010-05-19 SI SI201030168T patent/SI2389923T1/sl unknown
- 2010-05-19 DK DK10005258.8T patent/DK2389923T3/da active
- 2010-05-19 PT PT100052588T patent/PT2389923E/pt unknown
- 2010-05-19 ES ES10005258T patent/ES2403121T3/es active Active
2011
- 2011-05-18 BR BR112012029212-9A patent/BR112012029212A2/pt not_active Application Discontinuation
- 2011-05-18 WO PCT/EP2011/002482 patent/WO2011144335A1/en not_active Ceased
- 2011-05-18 MA MA35461A patent/MA34314B1/fr unknown
- 2011-05-18 AP AP2012006597A patent/AP3151A/xx active
- 2011-05-18 US US13/695,785 patent/US8877817B2/en active Active
- 2011-05-18 CN CN201180024241.4A patent/CN102985069B/zh not_active Expired - Fee Related
- 2011-05-18 MY MYPI2012004801A patent/MY160458A/en unknown
- 2011-05-18 RU RU2012151433/15A patent/RU2519764C1/ru active
- 2011-05-18 UA UAA201214331A patent/UA104381C2/uk unknown
- 2011-05-18 CA CA2799666A patent/CA2799666C/en not_active Expired - Fee Related
2012
- 2012-10-29 TN TNP2012000516A patent/TN2012000516A1/en unknown
- 2012-11-15 ZA ZA2012/08605A patent/ZA201208605B/en unknown
2013
- 2013-03-04 HR HRP20130184AT patent/HRP20130184T1/hr unknown
- 2013-03-22 CY CY20131100241T patent/CY1113999T1/el unknown
- 2013-04-03 SM SM201300038T patent/SMT201300038B/xx unknown

Also Published As

Publication number	Publication date
CN102985069A (zh)	2013-03-20
WO2011144335A1 (en)	2011-11-24
US20130210922A1 (en)	2013-08-15
EP2389923A1 (en)	2011-11-30
MY160458A (en)	2017-03-15
SI2389923T1 (sl)	2013-06-28
CY1113999T1 (el)	2016-07-27
EP2389923B1 (en)	2013-01-30
CA2799666A1 (en)	2011-11-24
ZA201208605B (en)	2013-09-25
HK1182315A1 (en)	2013-11-29
PL2389923T3 (pl)	2013-06-28
MA34314B1 (fr)	2013-06-01
AP3151A (en)	2015-03-31
BR112012029212A2 (pt)	2020-09-29
CA2799666C (en)	2016-02-16
RU2519764C1 (ru)	2014-06-20
TN2012000516A1 (en)	2014-04-01
CN102985069B (zh)	2014-11-26
SMT201300038B (it)	2013-07-09
HRP20130184T1 (hr)	2013-05-31
ES2403121T3 (es)	2013-05-14
WO2011144335A8 (en)	2012-12-06
PT2389923E (pt)	2013-03-28
UA104381C2 (uk)	2014-01-27
AP2012006597A0 (en)	2012-12-31
US8877817B2 (en)	2014-11-04

Publication	Publication Date	Title
DK2616064T3 (da)	2019-11-11	Ketorolacformuleringer klar til anvendelse
DK2389923T3 (da)	2013-03-18	Stabil klar til brug injicerbar paracetamol-formulering
DK3170508T3 (da)	2020-01-02	Vaccineformuleringer
DK2387989T3 (da)	2014-10-20	Langtidsvirkende formuleringer med insuliner
DK2525798T3 (da)	2017-11-20	Anæstetisk formulering
PL2852279T3 (pl)	2016-12-30	Układ do szczotkowania zwierząt i sposób obsługi układu do szczotkowania zwierząt
EP2563135A4 (en)	2013-09-25	COMPOSITION FOR COMBATING PLANT DISEASES AND THEIR USE
HRP20180717T1 (hr)	2018-07-13	Formulacija suhog praška koja sadrži inhibitor fosfodiesteraze
DK2654736T3 (da)	2020-09-14	Hidtil ukendt farmaceutisk sammensætning
GT201200303A (es)	2014-04-29	Formulaciones farmacéuticas
EP2552212A4 (en)	2013-08-14	IMPROVED FORMULATION
BR112013000356A2 (pt)	2016-06-07	formulação farmacêutica injetável de malfalano
DK2590502T3 (da)	2014-09-08	Dyrebørsteanordning
FR2957252B1 (fr)	2016-04-08	Composition cosmetique
EP2623092A4 (en)	2015-12-02	COSMETIC COMPOSITION
IL228573A0 (en)	2013-12-31	Otamixaban formulations with improved stability
PT2908835T (pt)	2017-07-19	Formulações estáveis
PL2277546T3 (pl)	2015-10-30	Trwały, gotowy do użycia preparat paracetamolu do iniekcji
DK2642980T3 (da)	2020-06-22	Pædiatrisk formulering
BR112012029461A2 (pt)	2017-03-01	composição farmacêutica contendo solifenacina
BR112012029887A2 (pt)	2016-08-16	composição farmacêutica
CO6950489A2 (es)	2014-05-20	Formulación agroquímica y uso de la misma
FI9608U1 (fi)	2012-03-29	Formulaatiot
DK2598472T3 (da)	2015-07-06	Formuleringer
EP2863894A4 (en)	2015-12-16	fenofibrate